Sana Biotechnology, Inc. (SANA) › Shareholders' EquitySana Biotechnology, Inc. (SANA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$13.19M2019: -$142.54M2020: -$421.18M2021: $728.50M2022: $499.31M2023: $287.51M2024: $250.50M2025: $160.88M$160.88M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$160.88M-35.8%2024$250.50M-12.9%2023$287.51M-42.4%2022$499.31M-31.5%2021$728.50M+273.0%2020-$421.18M-195.5%2019-$142.54M-980.8%2018-$13.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share